Bilateral brachial plexus blocks in a patient of hypertrophic obstructive cardiomyopathy with hypertensive crisis

Rohini V Bhat Pai1, Harihar V Hegde, McB Santhosh

  • 1Department of Anaesthesiology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India.

Insights

This case study demonstrates the successful use of bilateral brachial plexus blocks for emergency surgery in a patient with hypertrophic obstructive cardiomyopathy (HOCM). This regional anesthesia technique managed complex comorbidities and avoided risks associated with general anesthesia.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Trauma Surgery

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents significant anesthetic challenges due to complex pathophysiology and potential perioperative complications.
  • Patients with HOCM often have co-morbidities like hypertension and diabetes, increasing surgical risks.
  • Emergency surgical interventions in HOCM patients require careful anesthetic planning to mitigate risks.

Purpose of the Study:

  • To present a case of successful anesthetic management for emergency surgery in a patient with HOCM.
  • To highlight the utility of bilateral brachial plexus blocks in a high-risk surgical scenario.
  • To discuss the considerations for regional anesthesia in patients with complex cardiac conditions.

Main Methods:

  • A 50-year-old male with known HOCM, hypertension (crisis), and diabetes underwent emergency limb trauma surgery.
  • Anesthesia was achieved using bilateral brachial plexus blocks, with careful attention to local anesthetic dosage and staggered administration.
  • Invasive monitoring and labetalol infusion were used for blood pressure management.

Main Results:

  • The patient successfully underwent emergency hemostasis and debridement of traumatic limb injuries under bilateral brachial plexus blocks.
  • The regional anesthesia technique effectively managed the patient's co-morbidities, including hypertensive crisis.
  • No local anesthetic toxicity was observed, indicating successful management of anesthetic risks.

Conclusions:

  • Bilateral brachial plexus blocks can be a safe and effective anesthetic option for emergency procedures in select HOCM patients.
  • Meticulous technique and careful dose calculation are crucial to prevent local anesthetic systemic toxicity (LAST).
  • Regional anesthesia, when carefully planned, can be a viable alternative to general anesthesia in high-risk surgical patients.

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...